R

PriceRein Therapeutics

RNTX

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.

Historical stock price chart and annual return over the past years

-76%

5 years

% Total

RNTX
-25%

5 years

Annual Return

RNTX